Smiths Group Plc (SMIN)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Smiths Group Plc (SMIN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011933
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Smiths Group plc (Smiths Group) is a technology company. It offers products and services for threat and contraband detection, medical devices, energy, and communications industries through five business divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. The company also sells disposable consumables and offers after-sales services to its customers. Smiths Group’s customer base includes various governmental agencies, hospitals, petrochemical companies, contractors, equipment manufacturers, service providers, aerospace engine and airframe manufacturers, domestic appliance manufacturers, and the US construction industry. The company has manufacturing and service facilities in several countries in Americas, Europe and Asia-Pacific. Smiths Group is headquartered in London, the UK.

Smiths Group Plc (SMIN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Smiths Group Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Smiths Group Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Smiths Group Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Smiths Group Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Smiths Group Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Smiths Group Plc, Medical Equipment, Deal Details 10
Partnerships 10
Acacia Research Enters Into Licensing Agreement With SMITHS MEDICAL ASD 10
Smiths Medical Enters into Distribution Agreement with Sommetrics 11
Smiths Medical Enters Into Technology Integration Agreement With Epic Systems 12
Smiths Medical Enters Into Distribution Agreement With Nexus Medical 13
Debt Offering 14
Smiths Group Completes Public Offering Of Notes Due 2022 For US$400 Million 14
Asset Transactions 15
CooperSurgical Acquires Wallace Product Line from Smiths Medical International for USD175.2 Million 15
Tandem Diabetes Care Acquires US Patents And Patent Applications From Smiths Medical 16
Smiths Group Plc – Key Competitors 17
Smiths Group Plc – Key Employees 18
Smiths Group Plc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Strategy And Business Planning 21
Nov 21, 2017: Growing in China with new Smiths Interconnect plan 21
Nov 21, 2017: Smiths Group: Growing in China with new Smiths Interconnect plant 22
Financial Announcements 23
Sep 22, 2017: Smiths Group announces results for the year ended 31 July 2017 23
Mar 24, 2017: Smiths Group Announces Interim results for the six months ended 31 January 2017 24
Sep 28, 2016: Smiths Group: Annual results for the year ended 31 July 2016 25
Corporate Communications 26
Oct 17, 2017: Smiths Group: Appointment of Chief Financial Officer Designate 26
May 23, 2017: Smiths Group Announces Arrangements In Respect Of Chris O’Shea’s Termination 27
May 19, 2017: Smiths Group Directorate Changes 28
Nov 24, 2016: Smiths announces new Non-executive Director 29
Apr 27, 2016: Smiths announces new Non-executive Director 30
Jan 14, 2016: John Crane management change 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Smiths Group Plc, Medical Equipment, Key Facts, 2017 2
Smiths Group Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Smiths Group Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Smiths Group Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Smiths Group Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Smiths Group Plc, Deals By Market, 2011 to YTD 2017 8
Smiths Group Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Acacia Research Enters Into Licensing Agreement With SMITHS MEDICAL ASD 10
Smiths Medical Enters into Distribution Agreement with Sommetrics 11
Smiths Medical Enters Into Technology Integration Agreement With Epic Systems 12
Smiths Medical Enters Into Distribution Agreement With Nexus Medical 13
Smiths Group Completes Public Offering Of Notes Due 2022 For US$400 Million 14
CooperSurgical Acquires Wallace Product Line from Smiths Medical International for USD175.2 Million 15
Tandem Diabetes Care Acquires US Patents And Patent Applications From Smiths Medical 16
Smiths Group Plc, Key Competitors 17
Smiths Group Plc, Key Employees 18
Smiths Group Plc, Subsidiaries 19

★海外企業調査レポート[Smiths Group Plc (SMIN)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Obuv Rossii OOO (OBUV):企業の財務・戦略的SWOT分析
    Obuv Rossii OOO (OBUV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Checkpoint Therapeutics Inc (CKPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Checkpoint Therapeutics Inc (Checkpoint Therapeutics), a subsidiary of Fortress Biotech Inc, is a clinical-stage biopharmaceutical company that acquires, develops and commercializes non-chemotherapy and immune enhanced combination treatments for the treatment of solid tumor cancers. The comp …
  • GEA Group Aktiengesellschaft:企業の戦略・SWOT・財務分析
    GEA Group Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary GEA Group Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • PT Perusahaan Gas Negara (Persero) Tbk (PGAS):企業の財務・戦略的SWOT分析
    PT Perusahaan Gas Negara (Persero) Tbk (PGAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • ethris GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Ethris GmbH (Ethris) is a biotech company that develops RNA-based therapies. The company develops therapeutics based on its proprietary platform technologies. It uses technologies including magnetovax and SNIM RNA. Ethris’ magnetovax is a platform for personalized tumor vaccines localized an …
  • Major Drilling Group International Inc (MDI):企業の財務・戦略的SWOT分析
    Major Drilling Group International Inc (MDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Wacoal Holdings Corp (3591):企業の財務・戦略的SWOT分析
    Wacoal Holdings Corp (3591) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • F5 Networks, Inc.:企業の戦略・SWOT・財務情報
    F5 Networks, Inc. - Strategy, SWOT and Corporate Finance Report Summary F5 Networks, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Gene Techno Science Co Ltd (4584)-製薬・医療分野:企業M&A・提携分析
    Summary Gene Techno Science Co Ltd (GTS) is a developer and marketer of drug and antibodies for cancer, intractable diseases and rare diseases. The company develops biological and biosimilar products. Its biological pipeline products include GND-001 for immunological disease and oncology; GND-004, f …
  • Village Super Market, Inc.:企業の戦略・SWOT・財務情報
    Village Super Market, Inc. - Strategy, SWOT and Corporate Finance Report Summary Village Super Market, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Gazprom Neft (SIBN):石油・ガス:M&Aディール及び事業提携情報
    Summary Gazprom Neft, a subsidiary of Gazprom, is an integrated oil and gas company. It explores for, develops, and produces crude oil and natural gas. The company operates in Khanty-Mansi and Yamalo-Nenets Autonomous Districts, and Tomsk, Omsk and Orenburg regions in Russia; and also has production …
  • Calimmune Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Calimmune Inc (Calimmune), a subsidiary of CSL Behring Australia Pty Ltd, is a novel gene therapy program developer. The company’s ex vivio autulogus cell therapy includes CAL-1 and CAL-H. Its CAL-1 offers cell therapies for HIV AIDS. Calimmune’s CAL-H cell therapy provides himoglobinopathie …
  • Lockheed Martin Australia Pty Ltd:企業の戦略・SWOT・財務情報
    Lockheed Martin Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • GW Pharmaceuticals Plc (GWP):製薬・医療:M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …
  • Bone Biologics Corp (BBLG):企業の製品パイプライン分析
    Summary Bone Biologics Corp (Bone Biologics) is a biotechnology company that develops orthobiologic products. It develops NELL-1, a recombinant human protein growth factor, which is essential for normal bone development. It offers bone graft substitutes for spine fusion. Bone Biologics also offers N …
  • Old Mutual Plc:企業のM&A・事業提携・投資動向
    Old Mutual Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Old Mutual Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Michigan Public Power Agency:企業の戦略的SWOT分析
    Michigan Public Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Ceres Power Holdings plc (CWR):企業の財務・戦略的SWOT分析
    Summary Ceres Power Holdings Plc (Ceres Power) is an alternative energy company that develops low cost and next generation fuel cell technologies. The company carries out developing steel cell a fuel cell technology that converts natural gas and hydrogen fuel directly into electrical power and heat …
  • Cheniere Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Cheniere Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Cheniere Energy Inc (Cheniere) is a midstream energy company that owns and operates LNG-related businesses. The company through its general partner, Cheniere Energy Partners, L.P. (Cheniere Partners) …
  • Bird Rock Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary Bird Rock Bio Inc (Bird Rock Bio), formerly RuiYi Inc is a clinical stage biopharmaceutical company that develops immuno-inflammatory regulators. The company’s products under development include RYI-018 is a peripheral antagonist antibody to cannabinoid receptor 1 intended for the treatment …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆